BOLD vs GEN · P/E 0.1, $24.6M cap vs P/E 17, rev $5.00B
Boundless Bio, Inc. Common Stock (BOLD) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the BOLD and GEN stock pages for the full models.
Not investment advice.